Clinton Demands FDA Release Prepared Guidances on Insulin, Growth Hormone

Drug Industry Daily
A A

Sen. Hillary Clinton (D-N.Y.) wants the FDA’s Office of Generic Drugs (OGD) to turn over two biologic product guidances it allegedly drafted four years ago, the senator told the head of OGD at a hearing on Capitol Hill July 20.

To View This Article:

Login

Subscribe To Drug Industry Daily